DarioHealth (DRIO) Amortization of Deferred Charges (2023 - 2024)

DarioHealth's (DRIO) quarterly Amortization of Deferred Charges came in at $84000.0 in Q4 2024, up 221.74% YoY from $26108.1 in Q1 2024, and down 63.16% on a QoQ basis from $228000.0 in Q3 2024.

DarioHealth (DRIO) Amortization of Deferred Charges (2023 - 2024) Analysis & Trends

DarioHealth (DRIO) has 2 years of Amortization of Deferred Charges data on file, last reported at $84000.0 in Q4 2024.

  • Quarterly Amortization of Deferred Charges rose 221.74% year-over-year to $84000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $9000.0 (changed N/A YoY) and the FY2024 annual result came in at $516000.0, down 56.93% from the prior year.
  • Amortization of Deferred Charges declined to $84000.0 in Q4 2024, from $228000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $228000.0 in Q3 2024 to a low of -$234000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn
10 DarioHealth 70.92 Mn 56.96 Mn 3.19 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 84,000.00
Dec 31, 2024 84,000.00
Sep 30, 2024 228,000.00
Sep 30, 2024 228,000.00
Dec 31, 2023 -69,000.00
Dec 31, 2023 -69,000.00
Sep 30, 2023 -234,000.00
Sep 30, 2023 -234,000.00